289 related articles for article (PubMed ID: 17489736)
1. Prognostic biomarkers in renal cell carcinoma.
Jiang Z
Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
[TBL] [Abstract][Full Text] [Related]
2. Prognostic markers in renal cell carcinoma.
Ljungberg B
Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic molecular markers in renal cell carcinoma.
Tunuguntla HS; Jorda M
J Urol; 2008 Jun; 179(6):2096-102. PubMed ID: 18423738
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma and proteomics.
Sandim V; Pereira DA; Ornellas AA; Alves G
Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
[TBL] [Abstract][Full Text] [Related]
5. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
6. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
7. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
[TBL] [Abstract][Full Text] [Related]
8. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
Bukowski RM
Cancer; 2009 May; 115(10 Suppl):2273-81. PubMed ID: 19402065
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in clear cell renal cell carcinoma.
George S; Bukowski RM
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1737-47. PubMed ID: 18062748
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
13. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
15. Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
Rouvière O; Bouvier R; Négrier S; Badet L; Lyonnet D
Nat Clin Pract Oncol; 2006 Apr; 3(4):200-13. PubMed ID: 16596144
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
18. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
Lam JS; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
[TBL] [Abstract][Full Text] [Related]
19. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
Shah JB; Margulis V
Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for renal cell carcinoma.
Furniss D; Harnden P; Ali N; Royston P; Eisen T; Oliver RT; Hancock BW;
Cancer Treat Rev; 2008 Aug; 34(5):407-26. PubMed ID: 18440705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
